Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (3368)	12/18/1997 7:04:00 PM
From: Izzy	Read Replies (1) \| Respond to of 6136

Bill, what is "schitt"?

To: billkirn who wrote (3368)	12/18/1997 7:50:00 PM
From: JOHN W.	Read Replies (4) \| Respond to of 6136

I wonder who the the unamed analyst was? Of course Crossen, put his two cents in. I was one of those investors that that clamored for the company to do something, and then criticized when they did. Their damage control, may have not been perfect, but if the stock rebounded, we would be saying Donna and Peter are incredible. The real news is the Nov scrip data. Was this the reason for the comeback today to 30, while VRTX gave back most of their progress? Even if it was it will not have any immediate effect, since it is clear that AGPH will close at the 30 strike price tommorrow. Maybe then a rebound as a few number crunchers realize they keep selling the schitt out of this drug. David S.: I will be coming to see you so you can personally show me what crap I make up. In the long term, this change will be very beneficial to the company.